BCP Partnering Portal / Novilytic






Novilytic Secures Two Strategic Patents for its Proteometer Platform
https://www.novilytic.com/post/novilytic-secures-two-strategic-patents-for-its-proteometer-platform
Novilytic named a Finalist in BioTools Innvator's 2025 Competition
https://www.novilytic.com/post/novilytic-named-a-finalist-in-biotools-innovator-s-2025-competition
Novilytic is a company that helps upstream scientists in pharma and biopharma rapidly quantify mAb titer, aggregates, and charge variants directly from clarified fermentation broth. Their patented Proteometer technology eliminates the need for Protein A sample preparation, delivering actionable quality data in under 10 minutes. The platform simplifies workflows, reduces variability, and enables real-time process decisions. Novilytic's technology was developed by experts in analytical chemistry, and they offer a range of kits that analyze titer, aggregate, and charge variants of proteins containing a human Fc region.
Novilytic is an award-winning company who help scientists in pharma and biopharma to simplify the bioanalysis process for protein-based pharmaceuticals.
The technology was developed by some of the brightest minds in analytical chemistry are fortunate to have a team of world-class chemists and business professionals, including Dr. Fred Regnier, who will continue to develop their cutting-edge innovations.
Inspired by the saying “canary in the coal mine,” Novilytic is “The Canary in the Fermentor,” delivering near-real-time protein quality insights that help upstream scientists detect issues early and move quickly to the next sample.
Patented Proteometer® Technology developed for upstream scientists in pharma and biopharma.
Simplifies and speeds up the process of bioanalysis for Protein-Based Pharmaceuticals.
Removes the need for Protein A sample preparation.
Enables the near real time analysis of titer, aggregate, and charge variance.
Where Manufacturers and Channel Partners / Distributors find each other!